Quality Systems – Page 272

Phase Separation during bulk hold: mixing and sampling controls for QA review

Investigating Phase Separation During Bulk Hold: Essential Controls for Quality Assurance In the pharmaceutical manufacturing landscape, maintaining product integrity during storage is paramount. Phase separation during bulk hold can lead…

Coating Weight Variability after backing material change: root cause mapping across materials and process

Investigating Coating Weight Variability Following Backing Material Changes Coating weight variability is a common concern within pharmaceutical manufacturing, particularly following changes in backing materials. Fluctuations in coating weight can impact…

Color Change at accelerated stability: mixing and sampling controls for QA review

Identifying and Investigating Color Change During Accelerated Stability for Quality Assurance Color change during accelerated stability testing can present significant challenges in pharmaceutical manufacturing, particularly for topical and dermatological dosage…

Ivrt Failure during scale-up: root cause mapping across materials and process

Root Cause Mapping for IVRT Failures during Scale-Up in Pharmaceutical Manufacturing In the highly regulated world of pharmaceutical manufacturing, any deviations or out-of-specification (OOS) results can lead to significant disruptions,…

Osmolality Oos at stability pull: CAPA and effectiveness check plan

Osmolality is a critical parameter in ensuring the quality of pharmaceutical formulations, particularly in ophthalmic dosage forms. When an out-of-specification (OOS) result occurs during a stability pull, it can lead…

Dose Delivery Variability during lamination: inspection-ready documentation pack

Addressing Variability in Dose Delivery during Lamination: A Comprehensive Investigation In pharmaceutical manufacturing, particularly in the development of transdermal drug delivery systems, maintaining consistent dose delivery is crucial. When variability…

Texture Variability at accelerated stability: packaging compatibility and stability justification

Understanding Texture Variability During Accelerated Stability Testing in Pharmaceutical Manufacturing Texture variability observed during accelerated stability testing can raise significant concerns regarding product quality and consistency, particularly for topical and…

Ivpt Failure in transdermal patch manufacturing: packaging integrity and shelf-life justification

Investigation of IVPT Failures during Transdermal Patch Manufacturing: Packaging Integrity and Shelf-Life Considerations In the increasingly complex landscape of pharmaceutical manufacturing, ensuring the integrity and efficacy of transdermal patches poses…

Tag: Quality Systems

Phase Separation during bulk hold: mixing and sampling controls for QA review

Coating Weight Variability after backing material change: root cause mapping across materials and process

Color Change at accelerated stability: mixing and sampling controls for QA review

Ivrt Failure during scale-up: root cause mapping across materials and process

Osmolality Oos at stability pull: CAPA and effectiveness check plan

Dose Delivery Variability during lamination: inspection-ready documentation pack

Texture Variability at accelerated stability: packaging compatibility and stability justification

Ivpt Failure in transdermal patch manufacturing: packaging integrity and shelf-life justification

Texture Variability during shared equipment campaign: GMP investigation and CAPA strategy

Drug Crystallization after backing material change: GMP investigation plan and CAPA

E&L Failure during method transfer: sampling, filtration, and EM controls

Ph Drift during homogenization: mixing and sampling controls for QA review